A single-patient study conducted by British scientists found that Gilead’s remdesivir could be highly effective against Covid-19, raising questions about previous studies that found the antiviral drug had no impact on death rates from the disease.
According to a study published in Nature Communications, enzymes that are used by bacteria to break down mucus in the gut can potentially be useful biomarkers for intestinal diseases.
UK Institute Develops Llama-Derived Nanobodies as Possible Covid-19 Therapy
Cell, Clinical Trials, Coronavirus Disease 2019 (COVID-19), llamas, Nanobodies, Nature Communications, Nature Structural & Molecular Biology, Proteins, R&D, Rosalind Franklin Institute, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Nanobodies derived from llamas have neutralized the SARS-CoV-2 spike in the lab, effectively neutralizing the virus, according to research from the UK’s Rosalind Franklin Institute.
Investigators at the Case Western Reserve University School of Medicine identified a previously unknown gene and the resultant protein that may potentially slow the progress of Alzheimer’s disease.
Researchers at the University of Strathclyde in Glasgow, Scotland, potentially developed a blood test for brain cancer using high-throughput attenuated total reflection (ATR)-Fourier transform infrared (FTIR) spectroscopy with machine learning.
Researchers in Singapore believe that a drug used to treat tapeworms can be effective at treating a type of cancer.
Researchers from the University of Queensland’s Australian Institute for Bioengineering and Nanotechnology identified a nano-scaled DNA signature that seems to be common to all cancers.